Detail
Article
Online article
FT
Medvik - BMC
  • Something wrong with this record ?

Variation within 3'-UTRs of base excision repair genes and response to therapy in colorectal cancer patients: A potential modulation of microRNAs binding

B. Pardini, F. Rosa, E. Barone, C. Di Gaetano, J. Slyskova, J. Novotny, M. Levy, S. Garritano, L. Vodickova, T. Buchler, F. Gemignani, S. Landi, P. Vodicka, A. Naccarati,

. 2013 ; 19 (21) : 6044-56.

Language English Country United States

Document type Journal Article, Research Support, Non-U.S. Gov't

Persistent link   https://www.medvik.cz/link/bmc14063974

PURPOSE: Colorectal cancer is routinely treated with a 5-fluorouracil (5-FU)-based chemotherapy. 5-FU incorporates into DNA, and the base excision repair (BER) pathway specifically recognizes such damage. We investigated the association of single-nucleotide polymorphisms (SNP) in the 3'-untranslated regions (UTR) of BER genes, and potentially affecting the microRNA (miRNA) binding, on the risk of colorectal cancer, its progression, and prognosis. SNPs in miRNA-binding sites may modulate the posttranscriptional regulation of gene expression operated by miRNAs and explain interindividual variability in BER capacity and response to 5-FU. EXPERIMENTAL DESIGN: We tested 12 SNPs in the 3'-UTRs of five BER genes for colorectal cancer susceptibility in a case-control study (1,098 cases and 1,459 healthy controls). Subsequently, we analyzed the role of these SNPs on clinical outcomes of patients (866 in the Training set and 232 in the Replication set). RESULTS: SNPs in the SMUG1 and NEIL2 genes were associated with overall survival. In particular, SMUG1 rs2233921 TT carriers showed increased survival compared with those with GT/GG genotypes [HR, 0.54; 95% confidence interval (CI), 0.36-0.81; P = 0.003] in the Training set and after pooling results from the Replication set. The association was more significant following stratification for 5-FU-based chemotherapy (P = 5.6 × 10(-5)). A reduced expression of the reporter gene for the T allele of rs2233921 was observed when compared with the common G allele by in vitro assay. None of the genotyped BER polymorphisms were associated with colorectal cancer risk. CONCLUSIONS: We provide the first evidence that variations in miRNA-binding sites in BER genes 3'-UTR may modulate colorectal cancer prognosis and therapy response.

References provided by Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc14063974
003      
CZ-PrNML
005      
20140708102907.0
007      
ta
008      
140704s2013 xxu f 000 0|eng||
009      
AR
024    7_
$a 10.1158/1078-0432.CCR-13-0314 $2 doi
035    __
$a (PubMed)24036853
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a xxu
100    1_
$a Pardini, Barbara $u Authors' Affiliations: Human Genetics Foundation Torino; Department of Medical Sciences, University of Turin, Turin; Department of Biology, University of Pisa, Pisa; Laboratory of Computational Oncology, Center for Integrated Biology (CIBIO), University of Trento, Trento, Italy; Department of Molecular Biology of Cancer, Institute of Experimental Medicine; Departments of Surgery and Oncology, Thomayer Hospital; Institute of Biology and Department of Medical Genetics; and Department of Oncology, First Faculty of Medicine, Charles University, Prague, Czech Republic.
245    10
$a Variation within 3'-UTRs of base excision repair genes and response to therapy in colorectal cancer patients: A potential modulation of microRNAs binding / $c B. Pardini, F. Rosa, E. Barone, C. Di Gaetano, J. Slyskova, J. Novotny, M. Levy, S. Garritano, L. Vodickova, T. Buchler, F. Gemignani, S. Landi, P. Vodicka, A. Naccarati,
520    9_
$a PURPOSE: Colorectal cancer is routinely treated with a 5-fluorouracil (5-FU)-based chemotherapy. 5-FU incorporates into DNA, and the base excision repair (BER) pathway specifically recognizes such damage. We investigated the association of single-nucleotide polymorphisms (SNP) in the 3'-untranslated regions (UTR) of BER genes, and potentially affecting the microRNA (miRNA) binding, on the risk of colorectal cancer, its progression, and prognosis. SNPs in miRNA-binding sites may modulate the posttranscriptional regulation of gene expression operated by miRNAs and explain interindividual variability in BER capacity and response to 5-FU. EXPERIMENTAL DESIGN: We tested 12 SNPs in the 3'-UTRs of five BER genes for colorectal cancer susceptibility in a case-control study (1,098 cases and 1,459 healthy controls). Subsequently, we analyzed the role of these SNPs on clinical outcomes of patients (866 in the Training set and 232 in the Replication set). RESULTS: SNPs in the SMUG1 and NEIL2 genes were associated with overall survival. In particular, SMUG1 rs2233921 TT carriers showed increased survival compared with those with GT/GG genotypes [HR, 0.54; 95% confidence interval (CI), 0.36-0.81; P = 0.003] in the Training set and after pooling results from the Replication set. The association was more significant following stratification for 5-FU-based chemotherapy (P = 5.6 × 10(-5)). A reduced expression of the reporter gene for the T allele of rs2233921 was observed when compared with the common G allele by in vitro assay. None of the genotyped BER polymorphisms were associated with colorectal cancer risk. CONCLUSIONS: We provide the first evidence that variations in miRNA-binding sites in BER genes 3'-UTR may modulate colorectal cancer prognosis and therapy response.
650    12
$a 3' nepřekládaná oblast $7 D020413
650    _2
$a dospělí $7 D000328
650    _2
$a senioři $7 D000368
650    _2
$a senioři nad 80 let $7 D000369
650    _2
$a protokoly protinádorové kombinované chemoterapie $x terapeutické užití $7 D000971
650    _2
$a vazebná místa $7 D001665
650    _2
$a studie případů a kontrol $7 D016022
650    _2
$a kolorektální nádory $x farmakoterapie $x genetika $x mortalita $7 D015179
650    _2
$a oprava DNA $x genetika $7 D004260
650    _2
$a ženské pohlaví $7 D005260
650    12
$a genetická variace $7 D014644
650    _2
$a lidé $7 D006801
650    _2
$a mužské pohlaví $7 D008297
650    _2
$a mikro RNA $x genetika $x metabolismus $7 D035683
650    _2
$a lidé středního věku $7 D008875
650    _2
$a jednonukleotidový polymorfismus $7 D020641
650    _2
$a prognóza $7 D011379
650    _2
$a výsledek terapie $7 D016896
655    _2
$a časopisecké články $7 D016428
655    _2
$a práce podpořená grantem $7 D013485
700    1_
$a Rosa, Fabio
700    1_
$a Barone, Elisa
700    1_
$a Di Gaetano, Cornelia
700    1_
$a Slyskova, Jana
700    1_
$a Novotny, Jan
700    1_
$a Levy, Miroslav
700    1_
$a Garritano, Sonia
700    1_
$a Vodickova, Ludmila
700    1_
$a Buchler, Tomas
700    1_
$a Gemignani, Federica
700    1_
$a Landi, Stefano
700    1_
$a Vodicka, Pavel
700    1_
$a Naccarati, Alessio
773    0_
$w MED00001121 $t Clinical cancer research : an official journal of the American Association for Cancer Research $x 1078-0432 $g Roč. 19, č. 21 (2013), s. 6044-56
856    41
$u https://pubmed.ncbi.nlm.nih.gov/24036853 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y a $z 0
990    __
$a 20140704 $b ABA008
991    __
$a 20140708103157 $b ABA008
999    __
$a ok $b bmc $g 1031458 $s 862706
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2013 $b 19 $c 21 $d 6044-56 $i 1078-0432 $m Clinical cancer research $n Clin Cancer Res $x MED00001121
LZP    __
$a Pubmed-20140704

Find record

Citation metrics

Archiving options